Peripartum Cardiomyopathy and Pregnancy Associated Cardiomyopathy
Conditions
Interventions
None listed
Sponsors
National Cerebral and Cardiovascular Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Peripartum patients with risk factors of peripartum cardiomyopathy; pregnancy associated hypertension, multiple conseption, family history of dilated cardiomyopathy, usage of tocolitic agents
Exclusion criteria
Exclusion criteria: Patients without informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of peripartum cardiomyopathy among the study participants | — |
Secondary
| Measure | Time frame |
|---|---|
| The comparison of BNP levels between patients with and without peripartum cardiomyopathy | — |
Countries
Japan
Contacts
Public ContactChizuko Kamiya
National Cerebral and Cardiovascular Center The clinical investigation group for peripartum cardiomyopathy
Outcome results
None listed